In these tumors, the elimination of cancer cells with high CD38 levels is associated with an increase in helper T and cytotoxic T lymphocytes and a functional T-cell response.331,332 In these tumors, the use of monoclonal antibodies against CD38 is a promising therapy for the recovery of immune surveillance. This evidence concerns the gene CD38 and cancer.